PULSE BIOSCIENCES INC (PLSE:NASDAQ)
$32.79 2.56 (8.4684%)
Analysed PULSE BIOSCIENCES INC (PLSE:NASDAQ) News Sources
PLSE Q1 2026 Earnings Transcript
08-05-2026
fool.com
Pulse Biosciences Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?
10-05-2026
yahoo.com
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
17-05-2026
fool.com
Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy
26-05-2026
yahoo.com
Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?
09-06-2026
yahoo.com
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
10-06-2026
yahoo.com
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15-07-2026
yahoo.com
Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
21-07-2026
yahoo.com
This Little-Known Biotech Stock Just Hit a New 5-Year High
24-07-2026
barchart.com
What is the current price of PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The current price of PULSE BIOSCIENCES INC (PLSE:NASDAQ) is $32.79.
PULSE BIOSCIENCES INC (PLSE:NASDAQ) absolute price change since previous trading day?
The absolute price change of PULSE BIOSCIENCES INC (PLSE:NASDAQ) since the previous trading day is $2.56.
PULSE BIOSCIENCES INC (PLSE:NASDAQ) percentage price change since previous trading day?
The percentage price change of PULSE BIOSCIENCES INC (PLSE:NASDAQ) since the previous trading day is 8.4684%.
What is the most recent average sentiment score for PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The most recent average sentiment score for PULSE BIOSCIENCES INC (PLSE:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The most recent sentiment for PULSE BIOSCIENCES INC (PLSE:NASDAQ) is .
SEC-8K** Filing Available For PULSE BIOSCIENCES INC (PLSE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.